OptiNose (OPTN)

Currency in USD
9.600
-0.110(-1.13%)
Real-time Data·
Showing OptiNose historical data. For real-time data please try another search
Fair Value
Day's Range
9.4809.722
52 wk Range
4.81520.025
Key Statistics
Prev. Close
9.6
Open
9.67
Day's Range
9.48-9.722
52 wk Range
4.815-20.025
Volume
860.96K
Average Volume (3m)
112.64K
1-Year Change
-28.09%
Book Value / Share
-6.06
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
OPTN Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Currently not supported.

OptiNose News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Strong Sell
Moving Averages
Neutral

OptiNose Company Profile

OptiNose, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists. It offers XHANCE, a therapeutic product utilizing its proprietary exhalation delivery system (EDS) that delivers a topically acting corticosteroid for the treatment of chronic rhinosinusitis with nasal polyps, as well as is in Phase III clinical trial for treatment of chronic sinusitis; and Onzetra Xsail, a powder EDS device. The company was founded in 2000 and is headquartered in Yardley, Pennsylvania. As of May 21, 2025, OptiNose, Inc. operates as a subsidiary of Paratek Pharmaceuticals, Inc.

Employees
128

Compare OPTN to Peers and Sector

Metrics to compare
OPTN
Peers
Sector
Relationship
P/E Ratio
−3.3x0.0x−0.5x
PEG Ratio
−0.090.000.00
Price/Book
−1.6x0.0x2.6x
Price / LTM Sales
1.2x0.0x3.3x
Upside (Analyst Target)
−6.3%0.0%42.9%
Fair Value Upside
Unlock0.0%6.2%Unlock

Earnings

Latest Release
May 14, 2025
EPS / Forecast
-1.92 / -0.05
Revenue / Forecast
18.51M / 21.20M
EPS Revisions
Last 90 days

OPTN Income Statement

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.